Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised VEF in connection with a directed share issue whereby the company receives approximately SEK 885 million in issue proceeds.
Mandate

Vinge has advised VEF in connection with a directed share issue whereby the company receives approximately SEK 885 million in issue proceeds.

August 26, 2021 Capital Markets and Public M&A

The share issue was carried out as an accelerated book building process and directed to selected Swedish and international investors.

The company intends to use the expected net proceeds from the transaction in a value-added way both inside and outside of their current portfolio.

Vinge’s team consisted of Jesper Schönbeck, Joel Wahlberg and Anna Svensson.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025